Access the full text.
Sign up today, get DeepDyve free for 14 days.
Jennifer Owen, Vijaya Iragavarapu‐Charyulu, Z. Gunja-Smith, L. Herbert, J. Grosso, D. Lopez (2003)
Up-Regulation of Matrix Metalloproteinase-9 in T Lymphocytes of Mammary Tumor Bearers: Role of Vascular Endothelial Growth Factor 1The Journal of Immunology, 171
Y. DeClerck, S. Imren, A. Montgomery, B. Mueller, R. Reisfeld, W. Laug (1997)
Proteases and protease inhibitors in tumor progression.Advances in experimental medicine and biology, 425
Y Wang, W Kong, J Yue (2006)
Vascular endothelial growth factor165-regulated nasopharyngeal carcinoma cell lines invasion and migration involve expression and activation of matrix metalloproteinase-2J Huazhong Univ Sci Technolog Med Sci, 26
B. Glisson, B. Murphy, G. Frenette, F. Khuri, A. Forastiere (2002)
Phase II Trial of docetaxel and cisplatin combination chemotherapy in patients with squamous cell carcinoma of the head and neck.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 20 6
Y. Liang, P. Meleady, I. Cleary, S. Mcdonnell, L. Connolly, M. Clynes (2001)
Selection with melphalan or paclitaxel (Taxol) yields variants with different patterns of multidrug resistance, integrin expression and in vitro invasiveness.European journal of cancer, 37 8
G. Boguslawski, Patrick Mcglynn, Kevin Harvey, A. Kovala (2004)
SU1498, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Causes Accumulation of Phosphorylated ERK Kinases and Inhibits Their Activity in Vivo and in Vitro*Journal of Biological Chemistry, 279
J. Crown, M. O’Leary (2000)
The taxanes: an updateThe Lancet, 355
C. Cillo, V. Ling, R. Hill (1989)
Drug resistance in kht fibrosarcoma cell lines with different metastatic abilityInternational Journal of Cancer, 43
A. Chambers, A. Groom, I. Macdonald (2002)
Metastasis: Dissemination and growth of cancer cells in metastatic sitesNature Reviews Cancer, 2
E. Sauter, M. Nesbit, J. Watson, Andres Klein-Szanto, S. Litwin, M. Herlyn (1999)
Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck.Clinical cancer research : an official journal of the American Association for Cancer Research, 5 4
G. Klement, Ping Huang, B. Mayer, S. Green, S. Man, P. Bőhlen, D. Hicklin, R. Kerbel (2002)
Differences in therapeutic indexes of combination metronomic chemotherapy and an anti-VEGFR-2 antibody in multidrug-resistant human breast cancer xenografts.Clinical cancer research : an official journal of the American Association for Cancer Research, 8 1
Karl Miletti-González, Shiling Chen, N. Muthukumaran, G. Saglimbeni, Xiaohua Wu, Jinming Yang, Kevin Apolito, W. Shih, W. Hait, L. Rodriguez-Rodriguez (2005)
The CD44 receptor interacts with P-glycoprotein to promote cell migration and invasion in cancer.Cancer research, 65 15
P. Kyzas, D. Stefanou, A. Batistatou, N. Agnantis (2005)
Potential autocrine function of vascular endothelial growth factor in head and neck cancer via vascular endothelial growth factor receptor-2Modern Pathology, 18
Hao Wu, W. Hait, Jin-Ming Yang (2003)
Small interfering RNA-induced suppression of MDR1 (P-glycoprotein) restores sensitivity to multidrug-resistant cancer cells.Cancer research, 63 7
I. Stamenkovic (2000)
Matrix metalloproteinases in tumor invasion and metastasis.Seminars in cancer biology, 10 6
Feng-qiang Wang, J. So, Scott Reierstad, D. Fishman (2006)
Vascular endothelial growth factor–regulated ovarian cancer invasion and migration involves expression and activation of matrix metalloproteinasesInternational Journal of Cancer, 118
W. Fiedler, U. Graeven, S. Ergün, S. Verago, N. Kilic, M. Stockschläder, D. Hossfeld (1997)
Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia.Blood, 89 6
C. Cillo, J. Dick, V. Ling, R. Hill (1987)
Generation of drug-resistant variants in metastatic B16 mouse melanoma cell lines.Cancer research, 47 10
Yanjun Wang, W. Kong, J. Yue, Dawei Sun, Wei Li, Qi Yao, Yu Sun, Ji-hua Dong (2006)
Vascular endothelial growth factor165-regulated nasopharyngeal carcinoma cell lines invasion and migration involve expression and activation of matrix metalloproteinase-2Journal of Huazhong University of Science and Technology, 26
Yi Liang, L. O’Driscoll, S. Mcdonnell, P. Doolan, I. Oglesby, Kieran Duffy, R. O'Connor, M. Clynes (2004)
Enhanced in vitro invasiveness and drug resistance with altered gene expression patterns in a human lung carcinoma cell line after pulse selection with anticancer drugsInternational Journal of Cancer, 111
K. Scotlandi, M. Serra, G. Nicoletti, Monica Vaccari, M. Manara, Giuseppe Nini, L. Landuzzi, A. Colacci, G. Bacci, F. Bertoni, P. Picci, Mario Campanacci, Nicola Baldini (1996)
Multidrug resistance and malignancy in human osteosarcoma.Cancer research, 56 10
Li Li, A. Jiang, Pin Dong, Yi Wan, Zi Yu (2007)
The characteristics of Hep-2 cell with multiple drug resistance induced by TaxolOtolaryngology–Head and Neck Surgery, 137
L. Tao, Liang Zhou, Lu-ying Zheng, M. Yao (2006)
Elemene displays anti-cancer ability on laryngeal cancer cells in vitro and in vivoCancer Chemotherapy and Pharmacology, 58
Y. Liang, S. Mcdonnell, M. Clynes (2002)
Examining the relationship between cancer invasion/metastasis and drug resistance.Current cancer drug targets, 2 3
G. Morozevich, N. Kozlova, M. Preobrazhenskaya, N. Ushakova, I. Eltsov, A. Shtil, A. Berman (2006)
The role of β1 integrin subfamily in anchorage-dependent apoptosis of breast carcinoma cells differing in multidrug resistanceBiochemistry (Moscow), 71
G. Neufeld, T. Cohen, S. Gengrinovitch, Zoya Poltorak (1999)
Vascular endothelial growth factor (VEGF) and its receptorsThe FASEB Journal, 13
H. Yabushita, M. Shimazu, M. Noguchi, Tameko Kishida, H. Narumiya, K. Sawaguchi, M. Noguchi (2003)
Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.Oncology reports, 10 1
N. Ferrara, H. Gerber, J. Lecouter (2003)
The biology of VEGF and its receptorsNature Medicine, 9
E. Vokes, R. Weichselbaum, S. Lippman, Waun Hong (1993)
Head and Neck CancerThe New England journal of medicine, 328 3
R. Weinstein, S. Jakate, J. Dominguez, M. Lebovitz, G. Koukoulis, J. Kuszak, Larry Klusens, T. Grogan, T. Saclarides, I. Roninson, J. Coon (1991)
Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis.Cancer research, 51 10
Jin-Ming Yang, Zu-de Xu, Hao Wu, Hong-guang Zhu, Xiaohua Wu, W. Hait (2003)
Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells.Molecular cancer research : MCR, 1 6
AF Chambers, AC Groom, IC MacDonald (2002)
Dissemination and growth of cancer cells in metastatic sitesNat Rev Cancer., 2
M. Osmak, D. Nikšić, A. Brozovic, A. Ristov, I. Vrhovec, J. Škrk (1999)
Drug resistant tumor cells have increased levels of tumor markers for invasion and metastasis.Anticancer research, 19 4B
W. Lamoreaux, M. Fitzgerald, M. Fitzgerald, A. Reiner, K. Hasty, Steven Charles (1998)
Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro.Microvascular research, 55 1
K. Livak, Thomas Schmittgen (2001)
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.Methods, 25 4
J. Schneider, S. Gonzalez-Roces, M. Pollán, R. Lucas, A. Tejerina, Miguel Martín, A. Alba (2001)
Expression of LRP and MDR1 in locally advanced breast cancer predicts axillary node invasion at the time of rescue mastectomy after induction chemotherapyBreast Cancer Research, 3
P. O-Charoenrat, H. Modjtahedi, P. Rhys‐Evans, W. Court, G. Box, S. Eccles (2000)
Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.Cancer research, 60 4
MDR1/P-pg may be a risk predictor for the invasion of laryngeal cancer. MDR1 knock down and VEGFR-2 inhibitor may be two promising treatment regiments for advanced laryngeal carcinoma patients with MDR and invasion/metastasis.
Annals of Surgical Oncology – Springer Journals
Published: Feb 27, 2009
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.